PureTech Health plc Valuation
| PTCHFDelisted Stock | USD 3.13 0.00 0.00% |
At this time, the company appears to be overvalued. PureTech Health plc holds a recent Real Value of $2.68 per share. The prevailing price of the company is $3.13. Our model determines the value of PureTech Health plc from analyzing the company fundamentals such as Return On Equity of -0.0152, shares outstanding of 278.81 M, and Operating Margin of (9.87) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that PureTech Health's price fluctuation is very steady at this time. Calculation of the real value of PureTech Health plc is based on 3 months time horizon. Increasing PureTech Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PureTech pink sheet is determined by what a typical buyer is willing to pay for full or partial control of PureTech Health plc. Since PureTech Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PureTech Pink Sheet. However, PureTech Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.13 | Real 2.68 | Hype 3.13 |
The real value of PureTech Pink Sheet, also known as its intrinsic value, is the underlying worth of PureTech Health plc Company, which is reflected in its stock price. It is based on PureTech Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of PureTech Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of PureTech Health plc helps investors to forecast how PureTech pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PureTech Health more accurately as focusing exclusively on PureTech Health's fundamentals will not take into account other important factors: PureTech Health Total Value Analysis
PureTech Health plc is at this time forecasted to have takeover price of 654.5 M with market capitalization of 901.7 M, debt of 14.26 M, and cash on hands of 368.03 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the PureTech Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
654.5 M | 901.7 M | 14.26 M | 368.03 M |
PureTech Health Investor Information
About 15.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.61. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PureTech Health plc has Price/Earnings (P/E) ratio of 158.0. The entity recorded a loss per share of 0.21. The firm had not issued any dividends in recent years. PureTech Health plc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.PureTech Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. PureTech Health has an asset utilization ratio of 1.05 percent. This implies that the Company is making $0.0105 for each dollar of assets. An increasing asset utilization means that PureTech Health plc is more efficient with each dollar of assets it utilizes for everyday operations.PureTech Health Ownership Allocation
PureTech Health owns a total of 278.81 Million outstanding shares. The majority of PureTech Health plc outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in PureTech Health plc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in PureTech Health. Please pay attention to any change in the institutional holdings of PureTech Health plc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.PureTech Health Profitability Analysis
The company reported the revenue of 9.98 M. Net Loss for the year was (60.56 M) with profit before overhead, payroll, taxes, and interest of 17.39 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates PureTech Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in PureTech Health and how it compares across the competition.
About PureTech Health Valuation
The pink sheet valuation mechanism determines PureTech Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of PureTech Health. We calculate exposure to PureTech Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PureTech Health's related companies.PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. PURETECH HEALTH operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 95 people.
8 Steps to conduct PureTech Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates PureTech Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct PureTech Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain PureTech Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine PureTech Health's revenue streams: Identify PureTech Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research PureTech Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish PureTech Health's growth potential: Evaluate PureTech Health's management, business model, and growth potential.
- Determine PureTech Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate PureTech Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
PureTech Health Growth Indicators
Investing in growth stocks can be very risky. If the company such as PureTech Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 287.8 M | |
| Quarterly Earnings Growth Y O Y | 0.615 | |
| Retained Earnings | 199.9 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in PureTech Pink Sheet
If you are still planning to invest in PureTech Health plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PureTech Health's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |